Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Arbourmarkon Apr 28, 2021 8:44am
121 Views
Post# 33081086

RE:RE:RE:RE:RE:This stock

RE:RE:RE:RE:RE:This stock

Actuarial wrote: What's the point for you guys to discuss another reverse split? ATE has enough cash in bank!

 

I agree 100%, some posters too focussed on sp and qualifying for Nasdaq/NYSE. We have all the cash we need at this point. Management has clearly stated uplisting to major US exchange in the fall. They clearly know the requirements. They are currently in final negotiations to roll patents from holdco to ATE. They have a plan in place and are working it as we speak.

I believe some posters here have lost faith in management and purely base negative sentiment by referring to sp. Those who watch the sp by the day/hour/minute are not long investors nor do they understand how this sector works. Yes we could wake up one morning with blockbuster news and the sp could rocket to $20, $30, $40, $50 dollars but it could also take many months maybe another year to finish the dance and sales pitch to big pharma.

Another reverse split is nothing put pure nonsense.

<< Previous
Bullboard Posts
Next >>